Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low- and low–intermediate risk, aggressive non-Hodgkin’s lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG9508

2012 ◽  
Vol 96 (1) ◽  
pp. 74-83 ◽  
Author(s):  
Yoshitoyo Kagami ◽  
◽  
Kuniaki Itoh ◽  
Kensei Tobinai ◽  
Haruhiko Fukuda ◽  
...  
Keyword(s):  
Clinical Oncology ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Hodgkin's Lymphoma ◽  
Intermediate Risk ◽  
Newly Diagnosed ◽  
Oncology Group ◽  
Japan Clinical Oncology Group ◽  
Oncology Group Study ◽  
Chop Therapy

Phase II study of ABVd therapy for newly diagnosed clinical stage II–IV Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG 9305)

2010 ◽  
Vol 92 (5) ◽  
pp. 713-724 ◽  
Author(s):  
Michinori Ogura ◽  
Kuniaki Itoh ◽  
Tomohiro Kinoshita ◽  
Haruhiko Fukuda ◽  
Takeaki Takenaka ◽  
...  
Keyword(s):  
Hodgkin Lymphoma ◽  
Clinical Oncology ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Clinical Stage ◽  
Stage Ii ◽  
Newly Diagnosed ◽  
Oncology Group ◽  
Japan Clinical Oncology Group ◽  
Oncology Group Study

A Phase II Study of VEPA/FEPP Chemotherapy for Aggressive Lymphoma in Elderly Patients: Japan Clinical Oncology Group Study JCOG9203

2006 ◽  
Vol 83 (1) ◽  
pp. 55-62 ◽  
Author(s):  
Fumi Mizoroki ◽  
Yuko Hirose ◽  
Masayuki Sano ◽  
Haruhiko Fukuda ◽  
Kensei Tobinai ◽  
...  
Keyword(s):  
Elderly Patients ◽  
Clinical Oncology ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Aggressive Lymphoma ◽  
Oncology Group ◽  
Japan Clinical Oncology Group ◽  
Oncology Group Study
Sign in / Sign up

Export Citation Format

Share Document